Fasturtec Powder and Solvent for Solution for Infusion

Rasburicase
7.5 mg
SANOFI AVENTIS
Pack size 1 Vial
Dispensing mode
Source
Agent
Retail Price 1632.90 AED

Indications

Fasturtec Powder and Solvent for Solution for Infusion is used for: For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Rasburicase :

Mechanism of Action

Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin).

Note

Fasturtec 7.5 mg Powder and Solvent for Solution for Infusion manufactured by SANOFI AVENTIS. Its generic name is Rasburicase. Fasturtec is availble in Saudi Arabia. Farmaco SA drug index information on Fasturtec Powder and Solvent for Solution for Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Rasburicase :